{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T23:58:01Z","timestamp":1773791881182,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"DOI":"10.1007\/s10103-025-04502-y","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T23:19:35Z","timestamp":1748387975000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A comparative study of transurethral 450\u00a0nm DiLVP and 1470\u00a0nm DiLEP in the treatment of benign prostatic hyperplasia"],"prefix":"10.1007","volume":"40","author":[{"given":"Zhichao","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingfei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinghua","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengzhen","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"key":"4502_CR1","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1016\/j.juro.2008.03.141","volume":"179","author":"JT Wei","year":"2008","unstructured":"Wei JT, Calhoun E, Jacobsen SJ (2008) Urologic diseases in America project: benign prostatic hyperplasia. J Urol 179:S75\u2013S80","journal-title":"J Urol"},{"key":"4502_CR2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ucl.2016.04.006","volume":"43","author":"J-N Cornu","year":"2016","unstructured":"Cornu J-N (2016) Bipolar, monopolar, photovaporization of the prostate, or holmium laser enucleation of the prostate: how to choose what\u2019s best? Urol Clin North Am 43:377\u2013384","journal-title":"Urol Clin North Am"},{"key":"4502_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.juro.2013.01.061","volume":"190","author":"CW Fwu","year":"2013","unstructured":"Fwu CW, Eggers PW, Kaplan SA et al (2013) Long-term effects of Doxazosin, finasteride and combination therapy on quality of life in men with benign prostatic hyperplasia. J Urol 190:187\u2013193","journal-title":"J Urol"},{"issue":"2","key":"4502_CR4","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/path.2077","volume":"211","author":"N Sampson","year":"2007","unstructured":"Sampson N, Untergasser G, Plas E, Berger P (2007) The ageing male reproductive tract. J Pathol 211(2):206\u2013218","journal-title":"J Pathol"},{"issue":"5","key":"4502_CR5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.21037\/tau.2019.10.01","volume":"8","author":"SD Lokeshwar","year":"2019","unstructured":"Lokeshwar SD, Harper BT, Webb E et al (2019) Epidemiology and treatment modalities for the management of benign prostatic hyperplasia. Transl Androl Urol 8(5):529\u2013539","journal-title":"Transl Androl Urol"},{"key":"4502_CR6","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.juro.2018.05.048","volume":"200","author":"HE Foster","year":"2018","unstructured":"Foster HE, Barry MJ, Dahm P et al (2018) Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline. J Urol 200:612\u2013619","journal-title":"J Urol"},{"key":"4502_CR7","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.eururo.2005.12.072","volume":"49","author":"O Reich","year":"2006","unstructured":"Reich O, Gratzke C, Stief CG (2006) Techniques and long-term results of surgical procedures for BPH. Eur Urol 49:970\u2013978","journal-title":"Eur Urol"},{"key":"4502_CR8","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.eururo.2005.12.042","volume":"50","author":"J Rassweiler","year":"2006","unstructured":"Rassweiler J, Teber D, Kuntz R et al (2006) Complications of transurethral resection of the prostate (TURP)\u2014incidence, management, and prevention. Eur Urol 50:969\u2013980","journal-title":"Eur Urol"},{"key":"4502_CR9","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.juro.2008.03.058","volume":"180","author":"O Reich","year":"2008","unstructured":"Reich O, Gratzke C, Bachmann A et al (2008) Morbidity, mortality and early outcome of transurethral resection of the prostate: A prospective multicenter evaluation of 10,654 patients. J Urol 180:246\u2013249","journal-title":"J Urol"},{"issue":"6","key":"4502_CR10","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1007\/s11934-013-0351-8","volume":"14","author":"AA Kahokehr","year":"2013","unstructured":"Kahokehr AA, Gilling PJ (2013) Which laser works best for benign prostatic hyperplasia? Curr Urol Rep 14(6):614\u2013619","journal-title":"Curr Urol Rep"},{"issue":"4","key":"4502_CR11","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00345-014-1327-0","volume":"33","author":"L Lusuardi","year":"2015","unstructured":"Lusuardi L, Mitterberger M, Hruby S et al (2015) Update on the use of diode laser in the management of benign prostate obstruction in 2014. World J Urol 33(4):555\u2013562","journal-title":"World J Urol"},{"issue":"1","key":"4502_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ucl.2021.07.007","volume":"49","author":"D Elterman","year":"2022","unstructured":"Elterman D, Gao B, Lu S et al (2022) New technologies for treatment of benign prostatic hyperplasia. Urol Clin North Am 49(1):11\u201322","journal-title":"Urol Clin North Am"},{"issue":"1","key":"4502_CR13","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s12893-023-02266-2","volume":"23","author":"Z Fayou","year":"2023","unstructured":"Fayou Z, Jiude Z, Shuxian Z et al (2023) 1470 Nm laser is better for prostate hyperplasia treatment with different volume size via transurethral enucleation. BMC Surg 23(1):356","journal-title":"BMC Surg"},{"issue":"6","key":"4502_CR14","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1089\/end.2022.0705","volume":"37","author":"D Shao","year":"2023","unstructured":"Shao D, Zang Z, Li Z et al (2023) Efficacy and safety of 1470 Nm diode laser enucleation of the prostate in elderly benign prostatic hyperplasia patients. J Endourol 37(6):700\u2013705","journal-title":"J Endourol"},{"issue":"3","key":"4502_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1089\/end.2018.0499","volume":"33","author":"J Zhang","year":"2019","unstructured":"Zhang J, Wang X, Zhang Y et al (2019) 1470 Nm diode laser enucleation vs plasmakinetic resection of the prostate for benign prostatic hyperplasia: A randomized study. J Endourol 33(3):211\u2013217","journal-title":"J Endourol"},{"key":"4502_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML et al (2009) The clavien-dindo classification of surgical complications: Five-year experience. Ann Surg 250:187\u2013196","journal-title":"Ann Surg"},{"issue":"7","key":"4502_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11934-019-0899-z","volume":"20","author":"ZG Gul","year":"2019","unstructured":"Gul ZG, Kaplan SA (2019) BPH: why do patients fail medical therapy?? Curr Urol Rep 20(7):40","journal-title":"Curr Urol Rep"},{"key":"4502_CR18","doi-asserted-by":"crossref","unstructured":"Presicce F, De Nunzio C, Tubaro A. Is early benign prostatic hyperplasia (BPH) treatment worthwhile? Urologia. 2017 Aug 1;84(3):142-147.","DOI":"10.5301\/uj.5000251"},{"issue":"3","key":"4502_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.5301\/uro.5000220","volume":"84","author":"F Zattoni","year":"2017","unstructured":"Zattoni F, Ficarra V, Novara G (2017) Risk stratification for benign prostatic hyperplasia. Urologia 84(3):153\u2013157","journal-title":"Urologia"},{"issue":"3","key":"4502_CR20","first-page":"154","volume":"10","author":"KJ Gangavarapu","year":"2022","unstructured":"Gangavarapu KJ, Jowdy PF, Foster BA, Huss WJ (2022) Role of prostate stem cells and treatment strategies in benign prostate hyperplasia. Am J Clin Exp Urol 10(3):154\u2013169","journal-title":"Am J Clin Exp Urol"},{"key":"4502_CR21","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.eururo.2014.06.017","volume":"67","author":"J-N Cornu","year":"2015","unstructured":"Cornu J-N, Ahyai S, Bachmann A et al (2015) A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol 67:1066\u20131096","journal-title":"Eur Urol"},{"key":"4502_CR22","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.eururo.2010.06.005","volume":"58","author":"SA Ahyai","year":"2010","unstructured":"Ahyai SA, Gilling P, Kaplan SA et al (2010) Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 58:384\u2013397","journal-title":"Eur Urol"},{"key":"4502_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.urology.2020.01.008","volume":"138","author":"J Zhang","year":"2020","unstructured":"Zhang J, Li J, Wang X, Shi C, Tu M, Shi G (2020) Efficacy and safety of 1470-nm diode laser enucleation of the prostate in individuals with benign prostatic hyperplasia continuously administered oral anticoagulants or antiplatelet drugs. Urology 138:129\u2013133","journal-title":"Urology"},{"issue":"12","key":"4502_CR24","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1089\/pho.2013.3504","volume":"31","author":"Y Zhao","year":"2013","unstructured":"Zhao Y, Liu C, Zhou G, Yu C, Zhang Y, Ouyang Y (2013) A retrospective evaluation of benign prostatic hyperplasia treatment by transurethral vaporization using a 1470 Nm laser. Photomed Laser Surg 31(12):626\u2013629","journal-title":"Photomed Laser Surg"},{"issue":"2","key":"4502_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10103-017-2377-5","volume":"33","author":"Z Liu","year":"2018","unstructured":"Liu Z, Zhao Y, Wang X, Song M, Shi B (2018) Critical reviews of 1470-nm laser vaporization on benign prostatic hyperplasia. Lasers Med Sci 33(2):323\u2013327","journal-title":"Lasers Med Sci"},{"issue":"1","key":"4502_CR26","first-page":"24","volume":"28","author":"Z Fan","year":"2023","unstructured":"Fan Z, Cheng H, Du Q et al (2023) 450 Nm diode blue laser vaporescetion of the prostate: a report after 100 BPH procedures. J Mod Urol 28(1):24\u201328","journal-title":"J Mod Urol"},{"issue":"8","key":"4502_CR27","first-page":"702","volume":"28","author":"C Man","year":"2023","unstructured":"Man C, Hao X, Li T et al (2023) Sexual function\u2014preserving 450 am blue laser vaporization in the treatment of benign prostatic hyperplasia: a report of 20 cases. J Mod Urol 28(8):702\u2013706","journal-title":"J Mod Urol"},{"issue":"1","key":"4502_CR28","first-page":"29","volume":"28","author":"X Hao","year":"2023","unstructured":"Hao X, Li T, Tu F et al (2023) Clinical observation of blue laser in the treatment of benign prostatic hyperplasia. J Mod Urol 28(1):29\u201331","journal-title":"J Mod Urol"},{"issue":"1","key":"4502_CR29","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s10103-021-03297-y","volume":"37","author":"X Xu","year":"2022","unstructured":"Xu X, Jiang D, Liu G et al (2022) In vitro evaluation of the safety and efficacy of a high-power 450-nm diode blue laser in the treatment of benign prostate hyperplasia. Lasers Med Sci 37(1):555\u2013561","journal-title":"Lasers Med Sci"},{"issue":"10","key":"4502_CR30","first-page":"2077","volume":"13","author":"T Hughes","year":"2023","unstructured":"Hughes T, Harper P, Somani BK (2023) Treatment algorithm for management of benign prostatic obstruction: an overview of current techniques. Life (Basel) 13(10):2077","journal-title":"Life (Basel)"},{"issue":"1","key":"4502_CR31","doi-asserted-by":"publisher","first-page":"2257307","DOI":"10.1080\/13685538.2023.2257307","volume":"27","author":"X Xiao","year":"2024","unstructured":"Xiao X, Maolin X, Tao X et al (2024) Comparative analysis of the safety and efficacy of 1470-nm diode laser enucleation of the prostate and plasmakinetic resection of prostate in the treatment of large volume benign prostatic hyperplasia (>\u200980\u00a0ml). Aging Male 27(1):2257307","journal-title":"Aging Male"},{"issue":"8","key":"4502_CR32","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1089\/end.2020.1038","volume":"35","author":"A Ionson","year":"2021","unstructured":"Ionson A, Monfared SHB, Ursiny M et al (2021) Economic evaluation of 1470 Nm diode laser enucleation vs bipolar transurethral resection of the prostate. J Endourol 35(8):1204\u20131210","journal-title":"J Endourol"},{"issue":"1","key":"4502_CR33","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/nau.23317","volume":"37","author":"MC Cho","year":"2018","unstructured":"Cho MC, Park J, Kim JK et al (2018) Can preoperative detrusor underactivity influence surgical outcomes of 120\u00a0W HPS vaporization of the prostate (PVP) or holmium laser enucleation of the prostate (HoLEP)? A serial 3-year follow-up study. Neurourol Urodyn 37(1):407\u2013416","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"4502_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/1389450121666200925143916","volume":"22","author":"I Mykoniatis","year":"2021","unstructured":"Mykoniatis I, Renterghem KV, Sokolakis I (2021) How can we preserve sexual function after ablative surgery for benign prostatic hyperplasia?? Curr Drug Targets 22(1):4\u201313","journal-title":"Curr Drug Targets"},{"issue":"7","key":"4502_CR35","first-page":"CD013656","volume":"7","author":"JV Franco","year":"2021","unstructured":"Franco JV, Jung JH, Imamura M et al (2021) Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis. Cochrane Database Syst Rev 7(7):CD013656","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"4502_CR36","first-page":"133","volume":"69","author":"L Cindolo","year":"2017","unstructured":"Cindolo L, Marchioni M, Emiliani E, DE Francesco P, Primiceri G, Castellan P, Schips L (2017) Bladder neck contracture after surgery for benign prostatic obstruction. Minerva Urol Nefrol 69(2):133\u2013143","journal-title":"Minerva Urol Nefrol"},{"issue":"10","key":"4502_CR37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11934-017-0723-6","volume":"18","author":"G Primiceri","year":"2017","unstructured":"Primiceri G, Castellan P, Marchioni M, Schips L, Cindolo L (2017) Bladder neck contracture after endoscopic surgery for benign prostatic obstruction: incidence, treatment, and outcomes. Curr Urol Rep 18(10):79","journal-title":"Curr Urol Rep"},{"issue":"9","key":"4502_CR38","first-page":"748","volume":"28","author":"Y He","year":"2023","unstructured":"He Y, Liu S, Zou Z, Liang C (2023) 450 Am semiconductor blue laser vadorization combined with triamcinolone acetonide Inj ection in the treatment of bladder neck contracture: a case report. J Mod Urol 28(9):748\u2013750","journal-title":"J Mod Urol"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-025-04502-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-025-04502-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-025-04502-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T07:21:40Z","timestamp":1771399300000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-025-04502-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4502"],"URL":"https:\/\/doi.org\/10.1007\/s10103-025-04502-y","relation":{},"ISSN":["1435-604X"],"issn-type":[{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"18 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In accordance with the Declaration of Helsinki (2013 version), the study was approved by the Ethics Committee of Jinan Central Hospital, and informed consent was obtained from all human participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"246"}}